177 related articles for article (PubMed ID: 25026289)
1. Microsatellite instability and ploidy status define three categories with distinctive prognostic impact in endometrioid endometrial cancer.
Bilbao-Sieyro C; Ramírez R; Rodríguez-González G; Falcón O; León L; Torres S; Fernández L; Alonso S; Díaz-Chico N; Perucho M; Díaz-Chico JC
Oncotarget; 2014 Aug; 5(15):6206-17. PubMed ID: 25026289
[TBL] [Abstract][Full Text] [Related]
2. Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with endometrial carcinomas of the endometrioid type.
Zighelboim I; Goodfellow PJ; Gao F; Gibb RK; Powell MA; Rader JS; Mutch DG
J Clin Oncol; 2007 May; 25(15):2042-8. PubMed ID: 17513808
[TBL] [Abstract][Full Text] [Related]
3. Microsatellite instability as a marker of prognosis: a systematic review and meta-analysis of endometrioid endometrial cancer survival data.
Xiao JP; Wang JS; Zhao YY; Du J; Wang YZ
Arch Gynecol Obstet; 2023 Feb; 307(2):573-582. PubMed ID: 35665848
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients.
Sinicrope FA; Rego RL; Halling KC; Foster N; Sargent DJ; La Plant B; French AJ; Laurie JA; Goldberg RM; Thibodeau SN; Witzig TE
Gastroenterology; 2006 Sep; 131(3):729-37. PubMed ID: 16952542
[TBL] [Abstract][Full Text] [Related]
5. PIKing the type and pattern of PI3K pathway mutations in endometrioid endometrial carcinomas.
Marchiò C; De Filippo MR; Ng CK; Piscuoglio S; Soslow RA; Reis-Filho JS; Weigelt B
Gynecol Oncol; 2015 May; 137(2):321-8. PubMed ID: 25701704
[TBL] [Abstract][Full Text] [Related]
6. Relationship between genetic alterations and prognosis in sporadic colorectal cancer.
Chang SC; Lin JK; Yang SH; Wang HS; Li AF; Chi CW
Int J Cancer; 2006 Apr; 118(7):1721-7. PubMed ID: 16231316
[TBL] [Abstract][Full Text] [Related]
7. An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer.
Cosgrove CM; Tritchler DL; Cohn DE; Mutch DG; Rush CM; Lankes HA; Creasman WT; Miller DS; Ramirez NC; Geller MA; Powell MA; Backes FJ; Landrum LM; Timmers C; Suarez AA; Zaino RJ; Pearl ML; DiSilvestro PA; Lele SB; Goodfellow PJ
Gynecol Oncol; 2018 Jan; 148(1):174-180. PubMed ID: 29132872
[TBL] [Abstract][Full Text] [Related]
8. Microsatellite instability in endometrioid type endometrial adenocarcinoma is associated with poor prognostic indicators.
An HJ; Kim KI; Kim JY; Shim JY; Kang H; Kim TH; Kim JK; Jeong JK; Lee SY; Kim SJ
Am J Surg Pathol; 2007 Jun; 31(6):846-53. PubMed ID: 17527071
[TBL] [Abstract][Full Text] [Related]
9. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
[TBL] [Abstract][Full Text] [Related]
10. High frequency microsatellite instability has a prognostic value in endometrial endometrioid adenocarcinoma, but only in FIGO stage 1 cases.
Steinbakk A; Malpica A; Slewa A; Gudlaugsson E; Janssen EA; Arends M; Kruse AJ; Yinhua Y; Feng W; Baak JP
Anal Cell Pathol (Amst); 2010; 33(5):245-55. PubMed ID: 21079294
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of microsatellite instability (MSI) and PTEN expression in women with endometrial cancer: results from studies of the NCIC Clinical Trials Group (NCIC CTG).
Mackay HJ; Gallinger S; Tsao MS; McLachlin CM; Tu D; Keiser K; Eisenhauer EA; Oza AM
Eur J Cancer; 2010 May; 46(8):1365-73. PubMed ID: 20304627
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers and microsatellite instability analysis of curettings can predict the behavior of FIGO stage I endometrial endometrioid adenocarcinoma.
Steinbakk A; Malpica A; Slewa A; Skaland I; Gudlaugsson E; Janssen EA; Løvslett K; Fiane B; Kruse AJ; Feng W; Yinhua Y; Baak JP
Mod Pathol; 2011 Sep; 24(9):1262-71. PubMed ID: 21552210
[TBL] [Abstract][Full Text] [Related]
13. Assessing the prognostic role of ATR mutation in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study.
Zighelboim I; Ali S; Lankes HA; Backes F; Moore K; Mutch D; Robison K; Behbakht K; Waggoner S; Ghebre RG; Pearl M; Ramirez NC; Goodfellow P
Gynecol Oncol; 2015 Sep; 138(3):614-9. PubMed ID: 26144601
[TBL] [Abstract][Full Text] [Related]
14. Low-risk endometrial carcinoma: assessment of a treatment policy based on tumor ploidy and identification of additional prognostic indicators.
Lim P; Aquino-Parsons CF; Wong F; Dupuis B; Phillips D; Zhou C; Gilks CB
Gynecol Oncol; 1999 May; 73(2):191-5. PubMed ID: 10329033
[TBL] [Abstract][Full Text] [Related]
15. Sporadic colorectal adenocarcinomas with high-frequency microsatellite instability.
Gafà R; Maestri I; Matteuzzi M; Santini A; Ferretti S; Cavazzini L; Lanza G
Cancer; 2000 Nov; 89(10):2025-37. PubMed ID: 11066042
[TBL] [Abstract][Full Text] [Related]
16. Impact of microsatellite instability (MSI) on survival in high grade endometrial carcinoma.
Arabi H; Guan H; Kumar S; Cote M; Bandyopadhyay S; Bryant C; Shah J; Abdul-Karim FW; Munkarah AR; Ali-Fehmi R
Gynecol Oncol; 2009 May; 113(2):153-8. PubMed ID: 19275958
[TBL] [Abstract][Full Text] [Related]
17. ATR mutation in endometrioid endometrial cancer is associated with poor clinical outcomes.
Zighelboim I; Schmidt AP; Gao F; Thaker PH; Powell MA; Rader JS; Gibb RK; Mutch DG; Goodfellow PJ
J Clin Oncol; 2009 Jul; 27(19):3091-6. PubMed ID: 19470935
[TBL] [Abstract][Full Text] [Related]
18. Molecular markers in recurrent stage I, grade 1 endometrioid endometrial cancers.
Moroney MR; Davies KD; Wilberger AC; Sheeder J; Post MD; Berning AA; Fisher C; Lefkowits C; Guntupalli SR; Behbakht K; Corr BR
Gynecol Oncol; 2019 Jun; 153(3):517-520. PubMed ID: 30910249
[TBL] [Abstract][Full Text] [Related]
19. Microsatellite and chromosomal stable colorectal cancers demonstrate poor immunogenicity and early disease recurrence.
Banerjea A; Hands RE; Powar MP; Bustin SA; Dorudi S
Colorectal Dis; 2009 Jul; 11(6):601-8. PubMed ID: 18637931
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer.
Stasenko M; Tunnage I; Ashley CW; Rubinstein MM; Latham AJ; Da Cruz Paula A; Mueller JJ; Leitao MM; Friedman CF; Makker V; Soslow RA; DeLair DF; Hyman DM; Zamarin D; Alektiar KM; Aghajanian CA; Abu-Rustum NR; Weigelt B; Cadoo KA
Gynecol Oncol; 2020 Jan; 156(1):194-202. PubMed ID: 31757464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
